Orphan drugs and where to launch them: The keys to Europe’s forgotten territories
Pharmaceutical Technology
JULY 14, 2022
Despite this high number, orphan diseases are rare by definition, affecting around one in 2,000 people as defined by the European Union. These countries will have a smaller patient pool due to population size and will likely carry a price tag that is significantly below that of higher GDP countries.”. Go-to-market strategies.
Let's personalize your content